Skip to main content
OpenTrials

Clinical trial condition

Tumor Pathway Activations Inhibited by Dovitinib

Explore clinical trials studying Tumor Pathway Activations Inhibited by Dovitinib. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Tumor Pathway Activations Inhibited by Dovitinib trial results

Completed

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

NCT01831726

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +47 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Highlands Oncology Group SC Fayetteville, Arkansas, United States
  • PCR Oncology Pismo Beach, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 49 locations
View Trial Details

Related conditions